Circulating folic acid in plasma: relation to folic acid fortification

被引:103
作者
Kalmbach, Renee D. [1 ]
Choumenkovitch, Silvina F. [1 ]
Troen, Aron M. [1 ]
D'Agostino, Ralph [2 ]
Jacques, Paul F. [1 ]
Selhub, Jacob [1 ]
机构
[1] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA
[2] Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA USA
关键词
D O I
10.1093/ajcn/88.3.763
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: The implementation of folic acid fortification in the United States has resulted in unprecedented amounts of this synthetic form of folate in the American diet. Folic acid in circulation may be a useful measure of physiologic exposure to synthetic folic acid, and there is a potential for elevated concentrations after fortification and the possibility of adverse effects. Objective: We assessed the effect of folic acid fortification on circulating concentrations of folic acid and 5-methyltetrahydrofolate in the Framingham Offspring Cohort. Design: This is a cross-sectional study that used plasma samples from fasting subjects before and after fortification. Samples were measured for folate distribution with the use of an affinity-HPLC method with electrochemical detection. Results: Among nonsupplement users, the median concentration of folic acid in plasma increased from 0.25 to 0.50 nmol/L (P < 0.001) after fortification, and among supplement users the median increased from 0.54 to 0.68 nmol/L (P = 0.001). Among nonsupplement users, the prevalence of high circulating folic acid (>= 85th percentile) increased from 9.4% to 19.1% (P = 0.002) after fortification. Among supplement users, the prevalence of high circulating folic acid increased from 15.9% to 24.3% (P = 0.02). Folic acid intake and total plasma folate were positively and significantly related to high circulating folic acid after adjustment for potential confounding factors (P for trend < 0.001). Conclusions: Folic acid fortification has resulted in increased exposure to circulating folic acid. The biochemical and physiologic consequences of this are unknown, but these findings highlight the need to understand the effects of chronic exposure to circulating folic acid.
引用
收藏
页码:763 / 768
页数:6
相关论文
共 29 条
[1]  
Bagley PJ, 2000, CLIN CHEM, V46, P404
[2]   A randomized trial of aspirin to prevent colorectal adenomas [J].
Baron, JA ;
Cole, BF ;
Sandler, RS ;
Haile, RW ;
Ahnen, D ;
Bresalier, R ;
McKeown-Eyssen, G ;
Summers, RW ;
Rothstein, R ;
Burke, CA ;
Snover, DC ;
Church, TR ;
Allen, JI ;
Beach, M ;
Beck, GJ ;
Bond, JH ;
Byers, T ;
Greenberg, ER ;
Mandel, JS ;
Marcon, N ;
Mott, LA ;
Pearson, L ;
Saibil, F ;
van Stolk, RU .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899
[3]   Folic acid intake from fortification in United States exceeds predictions [J].
Choumenkovitch, SF ;
Selhub, J ;
Wilson, PWF ;
Rader, JI ;
Rosenberg, IH ;
Jacques, PF .
JOURNAL OF NUTRITION, 2002, 132 (09) :2792-2798
[4]  
DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4
[5]   FRAMINGHAM OFFSPRING STUDY - DESIGN AND PRELIMINARY DATA [J].
FEINLEIB, M ;
KANNEL, WB ;
GARRISON, RJ ;
MCNAMARA, PM ;
CASTELLI, WP .
PREVENTIVE MEDICINE, 1975, 4 (04) :518-525
[6]  
Food and Drug Administration, 1996, FED REGISTER, V61, P8781
[7]   Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects [J].
Honein, MA ;
Paulozzi, LJ ;
Mathews, TJ ;
Erickson, JD ;
Wong, LYC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (23) :2981-2986
[8]   The effect of folic acid fortification on plasma folate and total homocysteine concentrations [J].
Jacques, PF ;
Selhub, J ;
Bostom, AG ;
Wilson, PWF ;
Rosenberg, IH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1449-1454
[9]   Unmetabolized folic acid in serum: Acute studies in subjects consuming fortified food and supplements [J].
Kelly, P ;
McPartlin, J ;
Goggins, M ;
Weir, DG ;
Scott, JM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (06) :1790-1795
[10]  
LUCOCK M, 1989, EUR J CLIN NUTR, V43, P631